Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs

Diabetes, Obesity and Metabolism

Volumn 15, Issue 4, 2013, Pages 335-341

  Signorovitch, J E ^a   Macaulay, D ^a   Diener, M ^a   Yan, Y ^a   Wu, E Q ^a   Gruenberger, J B ^b   Frier, B M ^c  

^a ANALYSIS GROUP   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Antidiabetic drug; Glycaemic control; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT;

ACCIDENT; ADULT; AGED; ARTICLE; FALLING; HAZARD RATIO; HOSPITAL CARE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; TRAFFIC ACCIDENT;

EID: 84874300724     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12031     Document Type: Article

References (40)

1. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28: 2948-2961.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26: 1902-1912.
4. Redelmeier DA, Kenshole AB, Ray JG. Motor vehicle crashes in diabetic patients with tight glycemic control: a population-based case control analysis. PLoS Med 2009; 6: e1000192.
5. Rhoads GG, Orsini LS, Crown W, Wang S, Getahun D, Zhang Q. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med 2005; 47: 447-452.
6. Cox DJ, Penberthy JK, Zrebiek J et al. Diabetes and driving mishaps: frequency and correlations from a multinational survey. Diabetes Care 2003; 26: 2329-2334.
7. Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc 2007; 55: 2041-2044.
8. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51: S265-S280.
9. Begg IS, Yale JF, Houlden RL, Rowe RC, McSherry J. Canadian Diabetes Association's clinical practice guidelines for diabetes and private and commercial driving. Can J Diabetes 2012; 27: 128-140.
10. AMA. Physician's Guide to Assessing and Counseling Older Drivers. 2nd edn. Chicago, IL: American Medical Association, 2003; 1-235.
11. Laberge-Nadeau C, Dionne G, Ekoe JM et al. Impact of diabetes on crash risks of truck-permit holders and commercial drivers. Diabetes Care 2000; 23: 612-617.
12. Cox DJ, Gonder-Frederick L, Clarke W. Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes 1993; 42: 239-243.
13. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000; 23: 163-170.
14. Berlie HD, Garwood CL. Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother 2010; 44: 712-717.
15. Schwarz AV, Vittinghoff E, Sellmeyer DE et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008; 31: 391-396.
16. Johnston SS, Conner C, Aagren M, Ruiz K, Bouchard J. Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes. Diabetes Obes Metab 2012; 14: 634-643.
17. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-1147.
18. Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia. Diabetes Care 2008; 31: 2086-2091.
19. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004; 27: 17-20.
20. Harsch IA, Stocker S, Radespiel-Tröger M et al. Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens. J Intern Med 2002; 252: 352-360.
21. McGwin G, Sims RV, Pulley LV, Roseman JM. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol 2000; 152: 424-431.
22. Ginde AA, Espinola JA, Camargo CA. Trends and disparities in U.S. Emergency Department visits for hypoglycemia, 1993-2005. Diabetes Care 2008; 31: 511-513.
23. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301: 1565-1572.
24. Zhao Y, Fonsesca V, Campbell CR, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care 2012; 35: 1126-1132.
25. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
26. Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res 2006; 6: 84.
27. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008; 25: 245-254.
28. Waller J. Chronic medical conditions and traffic safety: review of the California experience. N Engl J Med 1965; 273: 1413-1420.
29. Elmehdawi RR, Mukhtad NA, Allaghi NI, Elmajberi SJ. Fasting of Ramadan in peoples with diabetes in Benghazi, Libya: an exploratory study. Libyan J Med 2010; 5: 5036.
30. Hassanein M, Hanif W, Malik W et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Curr Med Res Opin 2011; 27: 1367-1374.
31. Devendra D, Gohel B, Bravis V et al. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. Int J Clin Pract 2009; 63: 1446-1450.
32. van Doorn C, Gruber-Baldini AL, Zimmerman S et al. Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc 2003; 51: 1213-1218.
33. Oliver D, Britton M, Seed P, Martin FC, Hopper AH. Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: case control and cohort studies. BMJ 1997; 315: 1049-1053.
34. Lonnen KF, Powell RJ, Taylor D, Shore AC, MacLeod KM. Road traffic accidents and diabetes: insulin use does not determine risk. Diabet Med 2008; 25: 578-584.
35. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005; 58: 323-337.
36. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972.
37. Bolen S, Feldman L, Vassy J et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007; 147: 386-399.
38. Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diabetes Obes Metab 2007; 9: 194-205.
39. Garber AJ, Schweizer A, Baron MA, Rochotte E, Dejager S. Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study. Diabetes Obes Metab 2007; 9: 166-174.
40. Miller ME, Bonds DE, Gerstein HC et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: b5444.